<DOC>
	<DOCNO>NCT00110435</DOCNO>
	<brief_summary>The purpose 10-week study compare reduction cholesterol follow treatment two different market drug , patient type 2 diabetes mellitus hypercholesterolemia .</brief_summary>
	<brief_title>A Multicenter Study Evaluate Cholesterol Lowering Effects Two Marketed Products Patients With Type 2 Diabetes Mellitus Hypercholesterolemia ( MK-0653A-077 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Men woman age 18 79 year confirm diagnosis type 2 diabetes mellitus elevate cholesterol level may eligible participate study assess efficacy safety two market drug . Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus poorly control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>